切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2016, Vol. 10 ›› Issue (05) : 315 -323. doi: 10.3877/cma.j.issn.1674-0793.2016.05.001

所属专题: 文献 指南共识

专家共识

中国移植器官保护专家共识(2016版)
中国医师协会器官移植分会, 中华医学会外科学分会器官移植学组, 中国肝移植注册中心科学委员会   
  • 收稿日期:2016-09-05 出版日期:2016-10-01
  • 基金资助:
    国家863青年科学家项目(2015AA020923); 国家自然科学基金资助项目(815704025,81470891)

Chinese expert consensus on the organ protection of transplantation (2016 edition)

Chinese College of Transplantation Doctors, Division of Organ Transplatation, Branch of Surgery, Chinese Medical Association, China Liver Transplant Registry Scientific Committee   

  • Received:2016-09-05 Published:2016-10-01
引用本文:

中国医师协会器官移植分会, 中华医学会外科学分会器官移植学组, 中国肝移植注册中心科学委员会. 中国移植器官保护专家共识(2016版)[J]. 中华普通外科学文献(电子版), 2016, 10(05): 315-323.

Chinese College of Transplantation Doctors, Division of Organ Transplatation, Branch of Surgery, Chinese Medical Association, China Liver Transplant Registry Scientific Committee. Chinese expert consensus on the organ protection of transplantation (2016 edition)[J]. Chinese Archives of General Surgery(Electronic Edition), 2016, 10(05): 315-323.

表1 循证医学证据分级
表2 GRADE系统
表3 腹部器官获取及肝脏保存修复推荐共识意见
表4 肾脏保存修复推荐共识意见
表5 胰腺保存修复推荐共识意见
表6 小肠保存修复推荐共识意见
表7 心脏保存修复推荐共识意见
表8 肺保存修复推荐共识意见
1
Matsuno N,Uchida K,Furukawa H. Impact of machine perfusion preservation of liver grafts from donation after cardiac death[J]. Transplant Proceed, 2014, 46(4): 1099-1103.
2
Collins GM,Bravo-Shugarman M,Terasaki PI. Kidney preserva-tion for transportation. Initial perfusion and 30 hours′ ice storage[J]. Lancet, 1969, 2(7632): 1219-1222.
3
Lowalekar SK,Cao H,Lu XG, et al. Sub-normothermic preserva-tion of donor hearts for transplantation using a novel solution, So-mah: a comparative pre-clinical study[J]. J Heart Lung Trans-plant, 2014, 33(9): 963-970.
4
Jia JJ,Li JH,Jiang L, et al. Liver protection strategies in liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2015, 14(1): 34-42.
5
Schunemann HJ,Oxman AD,Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies[J]. BMJ, 2008, 336(7653): 1106-1110.
6
Brozek JL,Akl EA,Jaeschke R, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies[J]. Allergy, 2009, 64(8): 1109-1116.
7
Taner CB,Bulatao IG,Willingham DL, et al. Events in procure-ment as risk factors for ischemic cholangiopathy in liver transplan-tation using donation after cardiac death donors[J]. Liver Transpl, 2012, 18(1): 100-111.
8
Ho KJ,Owens CD,Johnson SR, et al. Donor postextubation hypo-tension and age correlate with outcome after donation after cardiac death transplantation[J]. Transplantation, 2008, 85(11): 1588-1594.
9
郑树森,徐骁,庄莉,等.中国心脏死亡捐献器官评估与应用专家共识[J].中华移植杂志, 2014, 8(8): 1-6.
10
de Vera ME,Lopez-Solis R,Dvorchik I, et al. Liver transplanta-tion using donation after cardiac death donors: long-term follow-up from a single center[J]. Am J Transplantat, 2009, 9(4): 773-781.
11
Hong JC,Yersiz H,Kositamongkol P, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive in-dex for graft failure-free survival[J]. Arch Surg, 2011, 146(9): 1017-1023.
12
Reich DJ,Mulligan DC,Abt PL, et al. ASTS recommended prac-tice guidelines for controlled donation after cardiac death organ procurement and transplantation[J]. Am J Transplant, 2009, 9(9): 2004-2011.
13
Kubal C,Mangus R,Fridell J, et al. Optimization of perioperative conditions to prevent ischemic cholangiopathy in donation after circulatory death donor liver transplantation[J]. Transplantation, 2016, 100(8): 1699-1704.
14
Hashimoto K,Eghtesad B,Gunasekaran G, et al. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors[J]. Am J Transplant, 2010, 10(12): 2665-2672.
15
Xia W,Ke Q,Wang Y, et al. Donation after cardiac death liver transplantation: Graft quality evaluation based on pretransplant liver biopsy[J]. Liver Transpl, 2015, 21(6): 838-846.
16
Pokorny H,Rasoul-Rockenschaub S,Langer F, et al. Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation-a prospective multi-centre observation study[J]. Transpl Int, 2004, 17(5): 256-260.
17
Corps CL,Ahmed I,McKenzie S, et al. Functional and histological comparison of rat liver preserved in University of Wisconsin solu-tion compared with tissue preserved in a novel solution[J]. Trans-plant Proc, 2010, 42(9): 3427-3430.
18
Yagi S,Doorschodt BM,Afify M, et al. Improved preservation and microcirculation with POLYSOL after partial liver transplantation in rats[J]. J Surg Res, 2011, 167(2): e375-383.
19
Jay C,Ladner D,Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant-an analysis of the national registry[J]. J Hepatol, 2011, 55(4): 808-813.
20
Dutkowski P,Schlegel A,de Oliveira M, et al. HOPE for human liver grafts obtained from donors after cardiac death[J]. J Hepatol, 2014, 60(4): 765-772.
21
Bruinsma BG,Yeh H,Ozer S, et al. Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation[J]. Am J Transplant, 2014, 14(6): 1400-1409.
22
Ravikumar R,Jassem W,Mergental H, et al. Liver Transplanta-tion After Ex Vivo Normothermic Machine Preservation: A Phase 1 (First-in-Man) Clinical Trial[J]. Am J Transplant, 2016, 16(6): 1779-1787.
23
贾俊君,李建辉,姜骊,等.肝移植供肝保存新途径:机械灌注[J].中华移植杂志, 2014, 8(3): 44-48.
24
Moers C,Smits JM,Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation[J]. N Engl J Med, 2009, 360(1): 7-19.
25
Watson CJ,Wells AC,Roberts RJ, et al. Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK multicenter randomized controlled trial[J]. Am J Transplant, 2010, 10(9): 1991-1999.
26
Belzer FO,Ashby BS,Dunphy JE. 24-hour and 72-hour preserva-tion of canine kidneys[J]. Lancet, 1967, 2(7515): 536-538.
27
Locke JE,Segev DL,Warren DS, et al. Outcomes of kidneys from donors after cardiac death: implications for allocation and preser-vation[J]. Am J Transplant, 2007, 7(7): 1797-1807.
28
曾宪鹏,叶啟发,王彦峰,等.低温机械灌注与冷保存应用于心脏死亡器官捐赠供肾效果的荟萃分析[J].中华器官移植杂志, 2015, 36(4): 225-230.
29
Jiao B,Liu S,Liu H, et al. Hypothermic machine perfusion reduc-es delayed graft function and improves one-year graft survival of kidneys from expanded criteria donors: a meta-analysis[J]. PloS One, 2013, 8(12): e81826.
30
Hosgood SA,Nicholson HF,Nicholson ML. Oxygenated kidney preservation techniques[J]. Transplantation, 2012, 93(5): 455-459.
31
Ploeg RJ,van Bockel JH,Langendijk PT, et al. Effect of preserva-tion solution on results of cadaveric kidney transplantation. The European Multicentre Study Group[J]. Lancet, 1992, 340(8812): 129-137.
32
Suntharalingam C,Sharples L,Dudley C, et al. Time to cardiac death after withdrawal of life-sustaining treatment in potential or-gan donors[J]. Am J Transplant, 2009, 9(9): 2157-2165.
33
Bernat JL,D′Alessandro AM,Port FK, et al. Report of a National Conference on Donation after cardiac death[J]. Am J Transplant, 2006, 6(2): 281-291.
34
Roels L,Coosemans W,Donck J, et al. Inferior outcome of cadav-eric kidneys preserved for more than 24 hr in histidine-trypto-phan-ketoglutarate solution. Leuven Collaborative Group for Transplantation[J]. Transplantation, 1998, 66(12): 1660-1664.
35
de Boer J,De Meester J,Smits JM, et al. Eurotransplant random-ized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins[J]. Transpl Int, 1999, 12(6): 447-453.
36
Belzer FO,Southard JH. Principles of solid-organ preservation by cold storage[J]. Transplantation, 1988, 45(4): 673-676.
37
Sui M,Zhang L,Yang J, et al. A new HC-A II solution for kidney preservation: a multi-center randomized controlled trial in China[J]. Ann Transplant, 2014, 19: 614-620.
38
Halloran P,Aprile M. A randomized prospective trial of cold stor-age versus pulsatile perfusion for cadaver kidney preservation[J]. Transplantation, 1987, 43(6): 827-832.
39
Rosenthal JT,Herman JB,Taylor RJ, et al. Comparison of pulsa-tile machine perfusion with cold storage for cadaver kidney preser-vation[J]. Transplantation, 1984, 37(4): 425-426.
40
Jaffers GJ,Banowsky LH. The absence of a deleterious effect of mechanical kidney preservation in the era of cyclosporine[J]. Transplantation, 1989, 47(4): 734-736.
41
Polyak MM,Arrington BO,Stubenbord WT, et al. The influence of pulsatile preservation on renal transplantation in the 1990s[J]. Transplantation, 2000, 69(2): 249-258.
42
钟自彪,叶啟发,范林,等.应用机械灌注保存心脏死亡器官捐献供肾的效果分析[J/CD].中华移植杂志:电子版, 2013, 7(1): 1-5.
43
Nyberg SL,Baskin-Bey ES,Kremers W, et al. Improving the pre-diction of donor kidney quality: deceased donor score and resistive indices[J]. Transplantation, 2005, 80(7): 925-929.
44
Vaziri N,Thuillier R,Favreau FD, et al. Analysis of machine per-fusion benefits in kidney grafts: a preclinical study[J]. J Transl Med, 2011, 9: 15.
45
Irish WD,Katz E. Cold machine perfusion or static cold storage of kidneys: why the debate continues[J]. Am J Transplant, 2010, 10(9): 1955-1956.
46
Kerr HR,Hatipoglu B,Krishnamurthi V. Pancreas transplant for diabetes mellitus[J]. Cleve Clin J Med, 2015, 82(11): 738-744.
47
Orlando G,Stratta RJ,Light J. Pancreas transplantation for type 2 diabetes mellitus[J]. Curr Opin Organ Transplant, 2011, 16(1): 110-115.
48
Tanioka Y,Hering BJ,Sutherland DE, et al. Effect of pancreatic warm ischemia on islet yield and viability in dogs[J]. Transplanta-tion, 1997, 64(12): 1637-1641.
49
Fridell JA,Powelson JA,Kubal CA, et al. Retrieval of the pancre-as allograft for whole-organ transplantation[J]. Clin Transplant, 2014, 28(12): 1313-1330.
50
Taylor MJ,Baicu S,Greene E, et al. Islet isolation from juvenile porcine pancreas after 24-h hypothermic machine perfusion pres-ervation[J]. Cell transplant, 2010, 19(5): 613-628.
51
Baertschiger RM,Berney T,Morel P. Organ preservation in pan-creas and islet transplantation[J]. Curr Opin Organ Transplant, 2008, 13(1): 59-66.
52
Squifflet JP,LeDinh H,de Roover A, et al. Pancreas preservation for pancreas and islet transplantation: a minireview[J]. Transplant Proc, 2011, 43(9): 3398-3401.
53
Vrakas G,Arantes RM,Gerlach U, et al. Solitary pancreas trans-plantation: a review of the UK experience over a period of 10 yr[J]. Clin Transplant, 2015, 29(12): 1195-1202.
54
Alexander M,Krishnan R,Buder B, et al. Impact of hypothermic preservation on tissue yield and viability in pig pancreata[J]. Transplant Proc, 2014, 46(6): 1975-1977.
55
Fridell JA,Mangus RS,Powelson JA. Organ preservation solutions for whole organ pancreas transplantation[J]. Curr Opin Organ Transplant, 2011, 16(1): 116-122.
56
Noguchi H,Naziruddin B,Onaca N, et al. Comparison of modified Celsior solution and M-kyoto solution for pancreas preservation in human islet isolation[J]. Cell Transplant, 2010, 19(6): 751-758.
57
Schneeberger S,Biebl M,Steurer W, et al. A prospective random-ized multicenter trial comparing histidine-tryptophane-ketogluta-rate versus University of Wisconsin perfusion solution in clinical pancreas transplantation[J]. Transpl Int, 2009, 22(2): 217-224.
58
Paushter DH,Qi M,Danielson KK, et al. Histidine-tryptophan-ketoglutarate and University of Wisconsin solution demonstrate equal effectiveness in the preservation of human pancreata intend-ed for islet isolation: a large-scale, single-center experience[J]. Cell Transplant, 2013, 22(7): 1113-1121.
59
Becker T,Ringe B,Nyibata M, et al. Pancreas transplantation with histidine-tryptophan-ketoglutarate (HTK) solution and University of Wisconsin (UW) solution: is there a difference?[J]. JOP, 2007, 8(3): 304-311.
60
Potdar S,Malek S,Eghtesad B, et al. Initial experience using histi-dine-tryptophan-ketoglutarate solution in clinical pancreas trans-plantation[J]. Clin Transplant, 2004, 18(6): 661-665.
61
Alonso D,Dunn TB,Rigley T, et al. Increased pancreatitis in al-lografts flushed with histidine-tryptophan-ketoglutarate solution: a cautionary tale[J]. Am J Transplant, 2008, 8(9): 1942-1945.
62
Esmaeilzadeh M,Fonouni H,Golriz M, et al. Evaluation of the mod-ified HTK solution in pancreas transplantation-An experimental model[J]. Asian J Surg, 2016, 39(2): 66-73.
63
Li X,Zhang J,Sang L, et al. Influence of the two-layer preserva-tion method on human pancreatic islet isolation: a meta-analysis[J]. Int J Artif Organs, 2015, 38(3): 117-125.
64
Scott WE 3rd,Weegman BP,Ferrer-Fabrega J, et al. Pancreas ox-ygen persufflation increases ATP levels as shown by nuclear mag-netic resonance[J]. Transplant Proc, 2010, 42(6): 2011-2015.
65
Iwanaga Y,Sutherland DE,Harmon JV, et al. Pancreas preserva-tion for pancreas and islet transplantation[J]. Curr Opin Organ Transplant, 2008, 13(4): 445-451.
66
Leeser DB,Bingaman AW,Poliakova L, et al. Pulsatile pump per-fusion of pancreata before human islet cell isolation[J]. Transplant Proc, 2004, 36(4): 1050-1051.
67
Valero R,Cabrer C,Oppenheimer F, et al. Normothermic recircu-lation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors[J]. Transplant Int, 2000, 13(4): 303-310.
68
Kuan KG,Wee MN,Chung WY, et al. Extracorporeal machine perfusion of the pancreas: technical aspects and its clinical impli-cations--a systematic review of experimental models[J]. Trans-plant Rev, 2016, 30(1): 31-47.
69
Taylor MJ,Baicu S,Leman B, et al. Twenty-four hour hypother-mic machine perfusion preservation of porcine pancreas facilitates processing for islet isolation[J]. Transplant Proc, 2008, 40(2): 480-482.
70
Liu F,Tian W,Yang Y, et al. Optimal method for short-term or long-term islet preservation: comparison of islet culture, cold pres-ervation and cryopreservation[J]. J Artif Organs, 2014, 17(4): 337-343.
71
Iyer KR. Surgical management of short bowel syndrome[J]. JPEN J Parenter Enteral Nutr, 2014, 38 (1 Suppl): 53s-59s.
72
Park PO,Haglund U,Bulkley GB, et al. The sequence of develop-ment of intestinal tissue injury after strangulation ischemia and re-perfusion[J]. Surgery, 1990, 107(5): 574-580.
73
Cicalese L,Sileri P,Green M, et al. Bacterial translocation in clin-ical intestinal transplantation[J]. Transplantation, 2001, 71(10): 1414-1417.
74
Kawai M,Kitade H,Koshiba T, et al. Intestinal Ischemia Reperfu-sion and Lipopolysaccharide Transform a Tolerogenic Signal into a Sensitizing Signal and Trigger Rejection[J]. Transplantation, 2009, 87(10): 1464-1467.
75
Abu-Elmagd K,Fung J,Bueno J, et al. Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor[J]. Ann Surg, 2000, 232(5): 680-687.
76
Muller AR,Nalesnik M,Platz KP, et al. Evaluation of preservation conditions and various solutions for small-bowel preservation[J]. Transplantation, 1994, 57(5): 649-655.
77
Ramisch D,Rumbo C,Echevarria C, et al. Long-Term outcomes of intestinal and multivisceral transplantation at a single center in Argentina[J]. Transplant Proc, 2016, 48(2): 457-462.
78
Abu-Elmagd K,Reyes J,Bond G, et al. Clinical intestinal trans-plantation: a decade of experience at a single center[J]. Ann Surg, 2001, 234(3): 404-416.
79
Abu-Elmagd KM,Costa G,Bond GJ, et al. Five hundred intesti-nal and multivisceral transplantations at a single center major ad-vances with new challenges[J]. Ann Surg, 2009, 250(4): 567-581.
80
Mangus RS,Tector AJ,Fridell JA, et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin so-lution in intestinal and multivisceral transplantation[J]. Transplan-tation, 2008, 86(2): 298-302.
81
Nickkholgh A,Contin P,Abu-Elmagd K, et al. Intestinal trans-plantation: review of operative techniques[J]. Clin Transplant, 2013, 27: 56-65.
82
Wei L,Hata K,Doorschodt BM, et al. Experimental small bowel preservation using Polysol: a new alternative to University of Wis-consin solution, Celsior and histidine-trytophan-ketoglutarate so-lution?[J]. World J Gastroenterol, 2007, 13(27): 3684-3691.
83
Tesi RJ,Jaffe BM,McBride V, et al. Histopathologic changes in human small intestine during storage in viaspan organ preserva-tion solution[J]. Arch Pathol Lab Med, 1997, 121(7): 714-718.
84
Roskott AM,Nieuwenhuijs VB,Dijkstra G, et al. Small bowel pres-ervation for intestinal transplantation: a review[J]. Transpl Int, 2011, 24(2): 107-131.
85
Toledo-Pereyra LH,Najarian JS. Human small bowel preserva-tion: assessment of viability during storage[J]. Bol Asoc Med P R, 1979, 71(9): 336-341.
86
Zhu JZ,Castillo EG,Salehi P, et al. A novel technique of hypother-mic luminal perfusion for small bowel preservation[J]. Transplanta-tion, 2003, 76(1): 71-76.
87
Munoz-Abraham AS,Patron-Lozano R,Narayan RR, et al. Extra-corporeal hypothermic perfusion device for intestinal graft preser-vation to decrease ischemic injury during transportation[J]. J Gas-trointest Surg, 2016, 20(2): 313-321.
88
Hicks M,Hing A,Gao L, et al. Organ preservation[J]. Methods Mol Bio, 2006, 333: 331-374.
89
Brant SM,Rosenbaum DH,Cobert ML, et al. Effects of antegrade and retrograde machine perfusion preservation on cardiac function after transplantation in canines[J]. Transplant Proc, 2014, 46(5): 1601-1605.
90
Hassanein WH,Zellos L,Tyrrell TA, et al. Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function[J]. J Thorac Cardiovasc Surg, 1998, 116(5): 821-830.
91
Ardehali A,Esmailian F,Deng M, et al. Ex-vivo perfusion of do-nor hearts for human heart transplantation (PROCEED II): a pro-spective, open-label, multicentre, randomised non-inferiority trial[J]. Lancet, 2015, 385(9987): 2577-2584.
92
Cobert ML,Peltz M,West LM, et al. Importance of organ preserva-tion solution composition in reducing myocardial edema during machine perfusion for heart transplantation[J]. Transplant Proc, 2010, 42(5): 1591-1594.
93
Lee KC,Chang CY,Chuang YC, et al. Combined St. Thomas and histidine-tryptophan-ketoglutarat solutions for myocardial preser-vation in heart transplantation patients[J]. Transplant Proc, 2012, 44(4): 886-889.
94
George TJ,Arnaoutakis GJ,Baumgartner WA, et al. Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation[J]. J Heart Lung Transplant, 2011, 30(9): 1033-1043.
95
Ackemann J,Gross W,Mory M, et al. Celsior versus custodiol: ear-ly postischemic recovery after cardioplegia and ischemia at 5 de-grees C[J]. Ann Thorac Surg, 2002, 74(2): 522-529.
96
Cannata A,Botta L,Colombo T, et al. Does the cardioplegic solu-tion have an effect on early outcomes following heart transplanta-tion?[J]. Eur J Cardiothoracic Surg, 2012, 41(4): e48-52.
97
Loganathan S,Radovits T,Hirschberg K, et al. Effects of Custodi-ol-N, a novel organ preservation solution, on ischemia/reperfusion injury[J]. J Thorac Cardiovasc Surg, 2010, 139(4): 1048-1056.
98
Desrois M,Caus T,Belles PM, et al. Limitation of myocardial and endothelial injury of the rat heart graft after preservation with Cen-tre de Resonance Magnetique Biologique et Medicale (CRMB) so-lution[J]. Transpl Int, 2008, 21(3): 276-283.
99
Klein AS,Messersmith EE,Ratner LE, et al. Organ donation and utilization in the United States, 1999-2008[J]. Am J Transplant, 2010, 10 (4 Pt 2): 973-986.
100
Sanchez PG,Rouse M,Pratt DL, et al. Lung donation after con-trolled circulatory determination of death: a review of current prac-tices and outcomes[J]. Transplant Proc, 2015, 47(6): 1958-1965.
101
Levvey BJ,Harkess M,Hopkins P, et al. Excellent clinical out-comes from a national donation-after-determination-of-cardiac-death lung transplant collaborative[J]. Am J Transplant, 2012, 12(9): 2406-2413.
102
Cypel M,Levvey B,Van Raemdonck D, et al. International Soci-ety for Heart and Lung Transplantation Donation After Circulatory Death Registry Report[J]. J Heart Lung Transplant, 2015, 34(10): 1278-1282.
103
Munshi L,Keshavjee S,Cypel M. Donor management and lung preservation for lung transplantation[J]. Lancet Respir Med, 2013, 1(4): 318-328.
104
Levvey BJ,Westall GP,Kotsimbos T, et al. Definitions of warm ischemic time when using controlled donation after cardiac death lung donors[J]. Transplantation, 2008, 86(12): 1702-1706.
105
Mascia L,Pasero D,Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial[J]. Jama, 2010, 304(23): 2620-2627.
106
Ganesh JS,Rogers CA,Banner NR, et al. Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures[J]. J Thorac Cardiovasc Surg, 2007, 134(5): 1313-1321.
107
王振兴,陈静瑜,郑明峰,等.肺移植供肺获取100例:冷缺血时间>6 h及肺减容对预后的影响[J].中国组织工程研究, 2012, 16(5): 835-838.
108
Marasco SF,Bailey M,McGlade D, et al. Effect of donor preserva-tion solution and survival in lung transplantation[J]. J Heart Lung Transplant, 2011, 30(4): 414-419.
109
Okada Y,Kondo T. Impact of lung preservation solutions, Euro-Collins vs. low-potassium dextran, on early graft function: a re-view of five clinical studies[J]. Ann Thorac Cardiovasc Surg, 2006, 12(1): 10-14.
110
Warnecke G,Moradiellos J,Tudorache I, et al. Normothermic per-fusion of donor lungs for preservation and assessment with the Or-gan Care System Lung before bilateral transplantation: a pilot study of 12 patients[J]. Lancet, 2012, 380(9856): 1851-1858.
111
Oniscu GC,Randle LV,Muiesan P, et al. In situ normothermic re-gional perfusion for controlled donation after circulatory death--the United Kingdom experience[J]. Am J Transplant, 2014, 14(12): 2846-2854.
112
Machuca TN,Mercier O,Collaud S, et al. Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion[J]. Am J Transplant, 2015, 15(4): 993-1002.
113
Cypel M,Yeung JC,Liu M, et al. Normothermic ex vivo lung per-fusion in clinical lung transplantation[J]. N Engl J Med, 2011, 364(15): 1431-1440.
No related articles found!
阅读次数
全文


摘要